Anna Finnes1, Pia Enebrink, Filipa Sampaio, Kimmo Sorjonen, JoAnne Dahl, Ata Ghaderi, Anna Nager, Inna Feldman. 1. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden (Ms Finnes, Drs Enebrink, Sorjonen, Ghaderi); Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (Drs Sampaio, Feldman); Department of Psychology, Uppsala University, Uppsala, Sweden (Dr Dahl); and Department of Neurobiology, Care Sciences and Society, Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden (Dr Nager).
Abstract
OBJECTIVE: The aim of this study was to evaluate cost-effectiveness of Acceptance and Commitment Therapy (ACT) and workplace dialogue intervention (WDI), both as stand-alone interventions and in combination, compared with treatment as usual (TAU), for employees on sickness absence with mental disorders. METHODS:Employees (n = 352, 78.4% females) on sickness absence were randomized to one of four groups. Cost-utility analyses were conducted from a health care perspective and a limited societal perspective. RESULTS: All groups reported significant improvements in health-related quality-of-life (HRQoL) and there were no significant differences in HRQoL or costs between groups. The probability of cost-effectiveness for ACT+WDI was 50% compared with ACT, indicating that both treatment alternatives could be considered equally favorable for decision-makers. TAU and WDI were rejected due to less economic efficiency. CONCLUSION: Adding WDI to ACT cannot be recommended on the basis of our study results.
RCT Entities:
OBJECTIVE: The aim of this study was to evaluate cost-effectiveness of Acceptance and Commitment Therapy (ACT) and workplace dialogue intervention (WDI), both as stand-alone interventions and in combination, compared with treatment as usual (TAU), for employees on sickness absence with mental disorders. METHODS: Employees (n = 352, 78.4% females) on sickness absence were randomized to one of four groups. Cost-utility analyses were conducted from a health care perspective and a limited societal perspective. RESULTS: All groups reported significant improvements in health-related quality-of-life (HRQoL) and there were no significant differences in HRQoL or costs between groups. The probability of cost-effectiveness for ACT+WDI was 50% compared with ACT, indicating that both treatment alternatives could be considered equally favorable for decision-makers. TAU and WDI were rejected due to less economic efficiency. CONCLUSION: Adding WDI to ACT cannot be recommended on the basis of our study results.
Authors: Anna Finnes; Jeffrey S Hoch; Pia Enebrink; JoAnne Dahl; Ata Ghaderi; Anna Nager; Inna Feldman Journal: Scand J Work Environ Health Date: 2022-01-30 Impact factor: 5.492